Your browser doesn't support javascript.
loading
Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Retinal Vein Occlusion: The Bevacizumab to Ranibizumab in Retinal Vein Occlusions (BRVO) study, a Randomized Trial.
Vader, Maartje J C; Schauwvlieghe, Ann-Sofie M E; Verbraak, Frank D; Dijkman, Greetje; Hooymans, Johanna M M; Los, Leonoor I; Zwinderman, Aeilko H; Peto, Tunde; Hoyng, Carel B; van Leeuwen, Redmer; Vingerling, Johannes R; de Jong-Hesse, Yvonne; van Lith-Verhoeven, Janneke J C; Dijkgraaf, Marcel G W; Schlingemann, Reinier O.
Afiliación
  • Vader MJC; Department of Ophthalmology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
  • Schauwvlieghe AME; Department of Ophthalmology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
  • Verbraak FD; Department of Ophthalmology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Dijkman G; Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands.
  • Hooymans JMM; Department of Ophthalmology, University Medical Center Groningen, and W. J. Kolff Institute, Graduate School of Medical Sciences, University of Groningen, Groningen, The Netherlands.
  • Los LI; Department of Ophthalmology, University Medical Center Groningen, and W. J. Kolff Institute, Graduate School of Medical Sciences, University of Groningen, Groningen, The Netherlands.
  • Zwinderman AH; Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
  • Peto T; Department of Ophthalmology, Queens University Belfast, Belfast, United Kingdom.
  • Hoyng CB; Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • van Leeuwen R; Department of Ophthalmology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Vingerling JR; Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • de Jong-Hesse Y; Department of Ophthalmology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • van Lith-Verhoeven JJC; Department of Ophthalmology, Elisabeth-Twee Steden (ETZ) Hospital, Tilburg, The Netherlands.
  • Dijkgraaf MGW; Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
  • Schlingemann RO; Department of Ophthalmology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands; Department of Ophthalmology, University of Lausanne, Jules-Gonin Eye Hospital, Lausanne, Switzerland. Electronic address: r.o.schlingemann@amsterdamumc.nl.
Ophthalmol Retina ; 4(6): 576-587, 2020 06.
Article en En | MEDLINE | ID: mdl-32107188
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Oclusión de la Vena Retiniana / Agudeza Visual / Edema Macular / Bevacizumab / Ranibizumab Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Ophthalmol Retina Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Oclusión de la Vena Retiniana / Agudeza Visual / Edema Macular / Bevacizumab / Ranibizumab Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Ophthalmol Retina Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos